Screener
Core Scientific, Inc. CORZ Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 28.3%+23.2pp | 16.9%+4.3pp | 11.9%-11.8pp | 6.6%-21.3pp | 5.1%-24.6pp | |
| Operating margin | -128.5%-78.1pp | -144.7%-86.4pp | -77%-49.2pp | -57.4%-44.3pp | -50.4%-42.8pp | |
| Efficiency | ||||||
| Asset turnover | 0.1×-0.1× | 0.2×-0.2× | 0.2×-0.3× | 0.2×-0.5× | 0.3×-0.5× | |
| Liquidity | ||||||
| Current ratio | 0.9×-0.9× | 0.5×-3.7× | 1.1×-5.6× | 1.6×-2.0× | 1.8×+0.2× | |
| Per Share | ||||||
| Book value per share | -$7.44-122% | -$4.04-709% | -$3.03+17.9% | -$3.54-25.3% | -$3.35+49.4% | |
| Valuation | ||||||
| Market capitalization | $7B+63.3% | $4.72B+121% | $4.51B+15.1% | $5.51B+160% | $3.64B+120% | |
| Price / sales | 15.9×+3.6× | 13.3×+8.1× | 14.2×+6.5× | 16.5×+12.7× | 10.4×+7.6× |
FAQ
- What are Core Scientific, Inc.'s profit margins?
- Core Scientific, Inc. (CORZ) runs a 28.3% gross margin and a -128.5% operating margin, with a -237.6% net margin.
- Where do Core Scientific, Inc.'s ratios come from?
- Every ratio is computed from Core Scientific, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
